Pazopanib for progressive desmoid tumors
Could cabozantinib be a successful novel therapy for mCRPC?
How will the results of the SPARTAN study impact US clinical practice in prostate cancer?
Erdafitinib for FGFR-mutated urothelial carcinoma
Chemotherapy vs. immunotherapy for the treatment of Merkel cell carcinoma